REGENHU, a leading, global provider of bioprinting technologies, announced today the opening of its office in Minnesota, United States, establishing its presence in North America. This company’s first office in the US, located in Medical Alley, Minnesota, officially opened its doors last Monday. It will serve as the central hub for delivering cutting-edge bioprinting solutions […]
REGENHU launches its next generation 3D Bioprinter and software, the R-GEN series and SHAPER, in its mission to revolutionize medicine
REGENHU, a leading global bioprinting company, today announced the launch of the R-GEN platform and SHAPER, a new bioprinter and software designed to cover the entire biofabrication process.
The REGENHU 3D bioprinters will be used to produce organoid-based tissues in the EU-funded project, OrganTrans.
SWISS INVESTMENT GROUP NIVALIS GROUP AND REGENHU’S BOARD OF DIRECTORS HAVE UNANIMOUSLY DECIDED TO APPOINT SIMON MACKENZIE AS THE NEW CEO OF REGENHU S.A., STARTING 11 NOVEMBER 2019.
Simon MacKenzie, 49 years old and a UK citizen, has a wealth of experience in biotech and Med Tech.